Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
3169 | 2048 | 41.2 | 80% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
144 | 3 | ENDOCRINOLOGY & METABOLISM//PITUITARY ADENOMA//GROWTH HORMONE | 64198 |
92 | 2 | GROWTH HORMONE//GROWTH HORMONE & IGF RESEARCH//ENDOCRINOLOGY & METABOLISM | 26472 |
3169 | 1 | GROWTH HORMONE DEFICIENCY//GROWTH HORMONE & IGF RESEARCH//GROWTH HORMONE | 2048 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | GROWTH HORMONE DEFICIENCY | authKW | 602540 | 10% | 21% | 196 |
2 | GROWTH HORMONE & IGF RESEARCH | journal | 265572 | 7% | 13% | 141 |
3 | GROWTH HORMONE | authKW | 187588 | 15% | 4% | 297 |
4 | KIMS MED OUTCOMES | address | 173467 | 1% | 73% | 16 |
5 | GH DEFICIENCY | authKW | 160436 | 2% | 22% | 49 |
6 | ADULT GROWTH HORMONE DEFICIENCY | authKW | 158272 | 1% | 56% | 19 |
7 | GROWTH HORMONE REPLACEMENT THERAPY | authKW | 119257 | 1% | 67% | 12 |
8 | HYPOPITUITARISM | authKW | 117898 | 4% | 10% | 83 |
9 | CLINICAL ENDOCRINOLOGY | journal | 110070 | 11% | 3% | 235 |
10 | GROWTH HORMONE REPLACEMENT | authKW | 101630 | 1% | 45% | 15 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Endocrinology & Metabolism | 89049 | 79% | 0% | 1620 |
2 | Pediatrics | 308 | 5% | 0% | 107 |
3 | Cell Biology | 233 | 8% | 0% | 154 |
4 | Medicine, General & Internal | 140 | 6% | 0% | 114 |
5 | Geriatrics & Gerontology | 92 | 1% | 0% | 29 |
6 | Physiology | 64 | 3% | 0% | 61 |
7 | Nutrition & Dietetics | 50 | 2% | 0% | 40 |
8 | Medicine, Research & Experimental | 30 | 3% | 0% | 55 |
9 | Health Policy & Services | 17 | 1% | 0% | 15 |
10 | Gerontology | 6 | 0% | 0% | 8 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | KIMS MED OUTCOMES | 173467 | 1% | 73% | 16 |
2 | MED M ENDOCRINOL DIABET | 76913 | 1% | 30% | 17 |
3 | ENDOCRINOL | 76882 | 24% | 1% | 484 |
4 | NEUROENDOCRINE UNIT | 74523 | 3% | 9% | 58 |
5 | MED ENDOCRINOL DIABET M | 69943 | 1% | 18% | 26 |
6 | KIGS | 60869 | 0% | 58% | 7 |
7 | PITUITARY UNIT | 47605 | 1% | 15% | 21 |
8 | ENDOCRINE CARE | 45424 | 0% | 38% | 8 |
9 | PL HTA | 44724 | 0% | 100% | 3 |
10 | SWEDISH PITUITARY | 34072 | 0% | 57% | 4 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | GROWTH HORMONE & IGF RESEARCH | 265572 | 7% | 13% | 141 |
2 | CLINICAL ENDOCRINOLOGY | 110070 | 11% | 3% | 235 |
3 | JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 98072 | 19% | 2% | 394 |
4 | EUROPEAN JOURNAL OF ENDOCRINOLOGY | 85273 | 8% | 3% | 172 |
5 | HORMONE RESEARCH | 49009 | 5% | 3% | 107 |
6 | PITUITARY | 18355 | 1% | 4% | 29 |
7 | ENDOCRINOLOGY AND METABOLISM | 6782 | 0% | 8% | 6 |
8 | METABOLISM-CLINICAL AND EXPERIMENTAL | 6602 | 3% | 1% | 63 |
9 | JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM | 5665 | 2% | 1% | 37 |
10 | JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION | 5027 | 2% | 1% | 41 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | MOLITCH, ME , CLEMMONS, DR , MALOZOWSKI, S , MERRIAM, GR , VANCE, ML , (2011) EVALUATION AND TREATMENT OF ADULT GROWTH HORMONE DEFICIENCY: AN ENDOCRINE SOCIETY CLINICAL PRACTICE GUIDELINE.JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. VOL. 96. ISSUE 6. P. 1587 -1609 | 137 | 67% | 185 |
2 | NILSSON, AG , SVENSSON, J , JOHANNSSON, G , (2007) MANAGEMENT OF GROWTH HORMONE DEFICIENCY IN ADULTS.GROWTH HORMONE & IGF RESEARCH. VOL. 17. ISSUE 6. P. 441-462 | 144 | 69% | 19 |
3 | STOCHHOLM, K , JOHANNSSON, G , (2015) REVIEWING THE SAFETY OF GH REPLACEMENT THERAPY IN ADULTS.GROWTH HORMONE & IGF RESEARCH. VOL. 25. ISSUE 4. P. 149 -157 | 91 | 83% | 6 |
4 | SIMPSON, H , SAVINE, R , SONKSEN, P , BENGTSSON, BA , CARLSSON, L , CHRISTIANSEN, JS , CLEMMONS, D , COHEN, P , HINTZ, R , HO, K , ET AL (2002) GROWTH HORMONE REPLACEMENT THERAPY FOR ADULTS: INTO THE NEW MILLENNIUM.GROWTH HORMONE & IGF RESEARCH. VOL. 12. ISSUE 1. P. 1 -33 | 156 | 67% | 55 |
5 | MOLLER, N , JORGENSEN, JOL , (2009) EFFECTS OF GROWTH HORMONE ON GLUCOSE, LIPID, AND PROTEIN METABOLISM IN HUMAN SUBJECTS.ENDOCRINE REVIEWS. VOL. 30. ISSUE 2. P. 152 -177 | 115 | 49% | 274 |
6 | GIOVANNINI, L , TIRABASSI, G , MUSCOGIURI, G , DI SOMMA, C , COLAO, A , BALERCIA, G , (2015) IMPACT OF ADULT GROWTH HORMONE DEFICIENCY ON METABOLIC PROFILE AND CARDIOVASCULAR RISK.ENDOCRINE JOURNAL. VOL. 62. ISSUE 12. P. 1037 -1048 | 88 | 80% | 0 |
7 | MOLITCH, ME , CLEMMONS, DR , MALOZOWSKI, S , MERRIAM, GR , SHALET, SM , VANCE, ML , (2006) EVALUATION AND TREATMENT OF ADULT GROWTH HORMONE DEFICIENCY: AN ENDOCRINE SOCIETY CLINICAL PRACTICE GUIDELINE.JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. VOL. 91. ISSUE 5. P. 1621 -1634 | 98 | 65% | 207 |
8 | LAURSEN, T , JORGENSEN, JOL , CHRISTIANSEN, JS , (2008) THE MANAGEMENT OF ADULT GROWTH HORMONE DEFICIENCY SYNDROME.EXPERT OPINION ON PHARMACOTHERAPY. VOL. 9. ISSUE 14. P. 2435 -2450 | 116 | 67% | 11 |
9 | CONCEICAO, FL , BOJENSEN, A , JORGENSEN, JOL , CHRISTIANSEN, JS , (2001) GROWTH HORMONE THERAPY IN ADULTS.FRONTIERS IN NEUROENDOCRINOLOGY. VOL. 22. ISSUE 3. P. 213 -246 | 119 | 79% | 11 |
10 | GAZZARUSO, C , GOLA, M , KARAMOUZIS, I , GIUBBINI, R , GIUSTINA, A , (2014) CARDIOVASCULAR RISK IN ADULT PATIENTS WITH GROWTH HORMONE (GH) DEFICIENCY AND FOLLOWING SUBSTITUTION WITH GH-AN UPDATE.JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. VOL. 99. ISSUE 1. P. 18-29 | 86 | 65% | 22 |
Classes with closest relation at Level 1 |